This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...